Does acarbose reduce the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance?
Acarbose treatment may be associated with a reduced risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance.
This study suggests that treating IGT patients with acarbose is associated with a significant reduction in the risk of cardiovascular disease and hypertension.
Chiasson et al. (Tue,) studied this question.